Federal Autism Advisory Committee Approves Contentious Strategic Plan Amid Vaccine Controversy and Leadership Shift
admin The Interagency Autism Coordinating Committee (IACC) convened on Thursday for a meeting that signaled a...
Health
Novartis Bolsters Cardiovascular Pipeline as Pacibekitug Meets Primary Endpoints in Phase 2 TRANQUILITY Trial.
The medical community gathered at the European Society of Cardiology (ESC) Congress 2024 in Munich...
AstraZeneca’s Heart Failure Setback and the Legal Battle Over GLP-1 Shortages: A Weekly Pharma Wrap-Up.
As the final days of August 2026 approach, the pharmaceutical landscape finds itself at a...
The Erosion of Scientific Consensus: Investigating RFK Jr.’s Samoa Testimony, the Reshaping of Autism Research, and the Future of Public Health
The landscape of American public health is currently navigating a period of unprecedented volatility, marked...
AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
The most recent surge in the autoimmune space centers on Roivant Sciences, the diversified biopharmaceutical...
Juul Labs Receives FDA Authorization for Next-Generation Vaping Device Featuring Age-Verification Technology.
In a landmark decision that signals a potential turning point for the embattled electronic cigarette...
Erasca Strengthens Leadership Pipeline with Appointment of Charles Fuchs as President of Research and Development.
In a move that signals a significant escalation in its quest to dominate the precision...
The Lindsay Clancy Case and the Looming Crisis of Defensive Medicine in Maternal Mental Health
The tragic case of Lindsay Clancy, the Duxbury, Massachusetts, mother accused of killing her three...
AstraZeneca’s Eplontersen Stumbles in ATTR-CM Trial: Analyzing the Impact of the Stabilizer Era on the Future of Cardiac Amyloidosis Treatments.
The landscape of the multibillion-dollar transthyretin amyloid cardiomyopathy (ATTR-CM) market underwent a seismic shift on...
Cytokinetics details trial win for what could be its next approval
The data unveiled on Friday stems from a pivotal Phase 3 study evaluating aficamten in...
